by OTMS Staff | Apr 23, 2026 | PatentVest Pulse, Uncategorized
PatentVest Pulse — The Triple-Agonist RacePatentVest PulseThe Triple-Agonist RaceRetatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market.April 2026Ozempic and Wegovy built a $50B market with 15% weight loss. Mounjaro and Zepbound...
by OTMS Staff | Mar 27, 2026 | Legal Reports
PatentVest Pulse Using AI In Your Inventive Process? Proceed to Patent, But Carefully Article | March 2026 The U.S. Patent and Trademark Office has sent a clear message to innovators: inventions involving AI may be patentable, including in biotech and healthcare, but...
by OTMS Staff | Feb 5, 2026 | Uncategorized
Author: Sarah Cork, Ph.D. Early-stage biotech companies generally understand that intellectual property management, in particular, patenting their crown-jewel technology, is a critical component of sound business strategy. But how might investment in the...
by OTMS Staff | Jan 13, 2026 | Uncategorized
Authors: Tyler Teske, Will Rosellini Executive Summary Where Value Will Actually Be Captured in the $1.8 Trillion Space Economy The global space economy represents a transformative $1.8 trillion opportunity at a critical inflection point. Driven by collapsing launch...
by OTMS Staff | Jul 9, 2025 | Uncategorized
Authors: Tyler Teske, Will Rosellini, Oscar Chow, and Lisette Chavez Highlights A $188B Market, with <6% Penetration: Robots are used in less than 6% of surgeries. Not because they don’t work, but because they’re too expensive and hard to set up. da Vinci Won the...
by OTMS Staff | Jun 18, 2025 | Uncategorized
Authors: Joanna Sadowska, Will Rosellini, Oscar Chow, Lisette Chavez 1. Executive Summary Cardiac stem cell therapy is not an emerging field. It is a space that has undergone a long period of setbacks, recalibration, and consolidation. After more than two...
Recent Comments